26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

III. Neurohypophysis<br />

587<br />

Arginine vasopressin (AVP) Cys.Tyr.Phe.Gln.Asn.Cys.Pro.Arg.Gly–NH 2<br />

Lysine vasopressin (LVP) - - - - - - - Lys -<br />

Arginine vasotocin (AVT) - - Ile - - - - - -<br />

Conopressin S (snail venom) - Phe.Ile.Arg - - - - -<br />

Mesotocin (MT) - - Ile - - - - Ile -<br />

Oxytocin (OT) - - Ile - - - - Leu -<br />

* * * * *<br />

FIGURE 18-14 Sequence comparison <strong>of</strong><br />

vasopressin (VP) and oxytocin (OT)-like peptides.<br />

Lines between shaded boxes represent<br />

intrachain disulfide bridges. See the legend for<br />

Figure 18-6 .<br />

hypothalamic neurons produces only one hormone, either<br />

VP or OT. The VP and OT genes are located within the<br />

same chromosomal locus at a very short distance from each<br />

other in a head-to-head orientation organization ( Burbach<br />

et al. , 2001 ). Regulatory domains in this intergenic region<br />

control their hypothalamus-specific expression ( Fields et al. ,<br />

2003 ).<br />

The VP gene consists <strong>of</strong> three exons that encode for<br />

different functional parts <strong>of</strong> the VP precursor peptide, the<br />

propressophysin. Exon 1 encodes the signal peptide, the<br />

nonapeptide VP, and the N-terminal part <strong>of</strong> neurophysin II<br />

(NP-II). Exon 2 encodes the central part <strong>of</strong> NP-II, and exon<br />

3 encodes the C-terminal part <strong>of</strong> NP-II and a glycoprotein<br />

(GP). The major factors that regulate VP expression are<br />

osmotic and hypovolemic stimuli. Water deprivation stimulates<br />

hypothalamic VP mRNA most probably through two<br />

cAMP response elements (CRE) and an AP2 site within<br />

the promoter. Glucocorticoids suppress VP gene expression<br />

through a GRE in the VP promoter ( Kim et al. , 2001 ).<br />

2 . (Pro)hormone<br />

After cleavage <strong>of</strong> the signal peptide, the GP moiety <strong>of</strong> the<br />

VP prohormone is glycosylated, disulfide bonds are generated,<br />

and then the prohormone is packaged into a secretory<br />

vesicle. The correct sorting <strong>of</strong> the prohormone into the<br />

secretory pathway requires the formation <strong>of</strong> aggregates.<br />

Specific association <strong>of</strong> VP and NP-II results in dimeric and<br />

tetrameric units that are essential for sorting ( Burbach et<br />

al. , 2001 ). The secretory vesicles are axonally transported<br />

to the axon endings in the posterior pituitary. Studies in<br />

the dog suggest that approximately 1.5 h are required from<br />

the time <strong>of</strong> synthesis to possible release <strong>of</strong> the nonapeptide<br />

( Ivell et al. , 1986 ). During this transport the neurophysin<br />

II, VP, and the GP moiety are liberated by proteolytic<br />

cleavage. The C-terminal glycine residue <strong>of</strong> the VP-molecule<br />

is finally amidated.<br />

In most mammals, VP contains an arginine residue at<br />

position 8 (arginine vasopressin, AVP) and a five-membered<br />

ring formed by a disulfide bridge between the<br />

cysteine residues at position 1 and 6 ( Fig. 18-14 ). In the<br />

members <strong>of</strong> the pig family, VP contains a lysine residue at<br />

position 8. The lysine vasopressin (LVP) is the only form<br />

present in the domestic pig. Heterozygotic peccaries, warthogs,<br />

and hippopotami may possess both AVP and LVP.<br />

Substitution <strong>of</strong> the phenylalanine residue at position 3 by<br />

isoleucine leads to arginine vasotocin (AVT). This peptide<br />

has been identified as a uniquely nonmammalian substance<br />

and is probably the most primitive and certainly the most<br />

commonly occurring neurohypophyseal peptide.<br />

3. Secretion<br />

The major determinant in the release <strong>of</strong> vasopressin is plasma<br />

osmolality. Below a certain plasma osmolality threshold,<br />

which may vary considerably between individuals, plasma<br />

VP concentration is suppressed to levels that allow maximal<br />

free water clearance ( Wade et al. , 1982 ). Once plasma<br />

osmolality rises to the threshold, the pituitary secretes VP.<br />

Although the concentration <strong>of</strong> plasma VP causing maximal<br />

antidiuresis is about 5 to 10 pmol/liter, the release <strong>of</strong> VP is<br />

related to plasma osmolality over a much broader range<br />

(Robertson, 1983 ). Biewenga et al. , developed a nomogram<br />

for this relationship in the dog, which allows analysis <strong>of</strong> the<br />

osmoregulation <strong>of</strong> VP secretion in terms <strong>of</strong> sensitivity and<br />

threshold ( Biewenga et al. , 1987 ). In healthy dogs, VP is<br />

secreted in a pulsatile fashion with a wide variation in number<br />

<strong>of</strong> pulses, VP pulse duration, and VP pulse amplitude<br />

and height ( van Vonderen et al. , 2004b ). After water deprivation,<br />

total and basal VP secretion, the number <strong>of</strong> significant<br />

VP pulses, as well as the pulse characteristics, is not different<br />

from basal values. However, during osmotic stimulation<br />

with hypertonic saline, there is a large increase in both basal<br />

and pulsatile VP secretion, and the number <strong>of</strong> VP pulses and<br />

VP pulse height and amplitude increase significantly ( van<br />

Vonderen et al. , 2004b ).<br />

Apart from the influence <strong>of</strong> osmolality, a significant<br />

decrease in circulating blood volume may also cause<br />

enhanced VP secretion. The decrease in left atrial pressure<br />

triggers receptors. Denervation <strong>of</strong> these receptors prevents<br />

the hypovolemia-mediated VP release. The functional<br />

properties <strong>of</strong> this regulatory system differ from those <strong>of</strong> the<br />

osmoregulatory system. Although the relationship between<br />

plasma osmolality and VP appears to be linear, the relationship<br />

between blood volume and plasma VP is best described<br />

by an exponential function ( Vokes and Robertson, 1985a ).<br />

Under ordinary circumstances, changes in VP levels are<br />

not observed until blood volume decreases by 5% to 10%.<br />

With further decreases, plasma VP rises exponentially. The<br />

relative insensitivity <strong>of</strong> VP to modest changes in blood volume<br />

means that this regulatory mechanism plays little or no<br />

role in the physiological control <strong>of</strong> water balance. Under<br />

ordinary circumstances, total body water rarely changes<br />

by more than 1% to 2%, an amount far too small to affect

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!